Neuren Pharmaceuticals | NEU - Equity Capital And Reserves

Stock Price
12.52
Daily Change
-0.68 -5.15%
Monthly
-31.51%
Yearly
-10.70%
Q1 Forecast
16.35

Neuren Pharmaceuticals reported AUD323.27M in Equity Capital and Reserves for its fiscal semester ending in June of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Clinuvel Pharmaceuticals AUD 203.01M 24.36M Jun/2024
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Genetic Signatures AUD 50.09M 4.5M Jun/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Medical Developments International AUD 55.1M 229K Jun/2025
Neuren Pharmaceuticals AUD 323.27M 40.63M Jun/2025
Organon & Co USD 906M 173M Sep/2025
Paradigm Biopharmaceuticals AUD 21.18M 12.88M Jun/2025
PYC Therapeutics AUD 170.01M 114.57M Jun/2025
Starpharma Holdings AUD 19M 4.17M Jun/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Telix Pharmaceuticals AUD 568.21M 164.24M Dec/2024
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025